Sexually Transmitted Diseases · 2013 · 22 citations · 18 references
MedicineInfectious DiseasesPreventive MedicineDiagnostic MicrobiologyEarly DetectionMolecular DiagnosticsAntibody ScreeningAntigen Detection AssaysImmunoassay AnalysisInfectious Disease Molecular TestingPathogen DetectionSerological DiagnosticsAntibody Detection TestsAntigen Detection TestsImmunoassay Screening ConfirmationPositive Predictive ValuePositive Predictive Value AnalysisScreening Algorithm DevelopmentSyphilis DiagnosticsSyphilis Screening
BACKGROUND: The widespread reverse syphilis screening algorithm involves 1 more treponemal test than the traditional screening algorithm, resulting in increased medical costs. In the first screening step of the algorithm, a chemiluminescence microparticle immunoassay is used to detect Treponema pallidum (TP) antibody on the basis of signal-to-cutoff (S/CO) ratios. We hypothesized that by analyzing S/CO ratios, we could determine a strategy to reduce unnecessary confirmatory testing. METHODS: The ARCHITECT Syphilis TP assay using the chemiluminescence microparticle immunoassay was used as a syphilis screening test, and all reactive results were followed up with a toluidine red unheated serum test (TRUST) and a TP particle agglutination (TPPA) assay. We evaluated the S/CO ratios of 319 reactive samples of a total of 8980 that were included in the screening tests. A receiver operating characteristic curve was used to determine the optimal S/CO ratio to predict confirmatory TPPA results. RESULTS: When the S/CO ratio was 9.9 or greater, the specificity and positive predictive value were both determined to be 100.0%. All samples (194/194) with S/CO ratios of 9.9 or greater, even with negative results for TRUST, were confirmed to be positive for treponemal antibody. CONCLUSIONS: A sample with an S/CO ratio of 9.9 or greater in initial screening does not need an extra confirmatory TPPA test, although the sample has a negative result for TRUST. We propose a potentially cost-effective reverse screening algorithm, obviating the need for the secondary treponemal testing in 65.2% of the screening-reactive samples.
18
IUSTI: 2008 European Guidelines on the Management of Syphilis
Patrick French, M.A. Gomberg, M. Janier et al. · International Journal of STD & AIDS · 2009 · 294 citations